Carvalho et al. used CCLE data (i.e., copy number and RNA-Seq expression data of colorectal cancer cell lines in CCLE) to identify cell line models and explore drug responses in rectal cancer, revealing significant findings related to the topoisomerase 2A (TOP2A) gene in separate patient cohorts [53]. This evidence concerns the gene TOP2A and rectal cancer.